Trellis Bioscience Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 11

Trellis Bioscience General Information

Description

Operator of a biotechnology company intended to leverage proprietary cellSpot technology to derive rare, naturally optimized antibodies from healthy donor blood against infectious diseases and cancer. The company's platform derives therapeutic antibodies directly from the human immune system to optimize human-derived antibodies against bacterial and viral infectious diseases, as well as cancer, enabling clients to get access to alternatives when the immune system attacks protein therapeutics providing patients with safe and effective medical care.

Contact Information

Website
www.trellisbio.com/home
Formerly Known As
Trellis Bioinformatics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 702 Marshall Street
  • Suite 301
  • Redwood City, CA 94063
  • United States
+1 (650)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 702 Marshall Street
  • Suite 301
  • Redwood City, CA 94063
  • United States
+1 (650)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trellis Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
21. Secondary Transaction - Private 23-Jun-2022 Completed Generating Revenue
20. Grant 01-Sep-2020 Completed Generating Revenue
19. Grant 13-Jan-2020 Completed Generating Revenue
18. Later Stage VC (Series B) 01-Jan-2019 Completed Generating Revenue
17. Debt - General Completed Generating Revenue
16. Grant 01-Jul-2014 Completed Generating Revenue
15. Grant 16-Aug-2012 Completed Generating Revenue
14. Debt - General 08-Nov-2011 Completed Generating Revenue
13. Grant 31-Aug-2011 $48.8M Completed Generating Revenue
12. Later Stage VC 09-Apr-2010 $48.8M Completed Generating Revenue
To view Trellis Bioscience’s complete valuation and funding history, request access »

Trellis Bioscience Patents

  • 198

    Total Documents Applications and Grants

  • Total Patents Families

  • 103

    Granted

  • 22

    Pending

  • Expiring in next 12 mo

Trellis Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4363456-A1 Anti-alk antibodies & uses thereof Pending 28-Jun-2021
US-20240254258-A1 Anti-alk antibodies and uses thereof Pending 28-Jun-2021
US-20240131508-A1 Diagnostics for emerging disease Pending 27-Apr-2021
US-20240226877-A9 Diagnostics for emerging disease Pending 27-Apr-2021
US-20220204600-A1 Therapeutic protein formulations comprising anti-dnabii antibodies and uses thereof Pending 30-Dec-2020 A61K31/427
To view Trellis Bioscience’s complete patent history, request access »

Trellis Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trellis Bioscience Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
CARB-X University
K2X Venture Capital Minority
Nodenza Venture Partners Venture Capital Minority
National Institute Of Allergy and Infectious Diseases Government
You’re viewing 5 of 11 investors. Get the full list »

Trellis Bioscience Acquisitions (1)

Trellis Bioscience’s most recent deal was a Merger/Acquisition with A-CUBE (Discovery Tools (Healthcare)). The deal was made on 01-Jan-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
A-CUBE (Discovery Tools (Healthcare)) 01-Jan-2013 Merger/Acquisition Discovery Tools (Healthcare)
To view Trellis Bioscience’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Trellis Bioscience FAQs

  • When was Trellis Bioscience founded?

    Trellis Bioscience was founded in 1998.

  • Where is Trellis Bioscience headquartered?

    Trellis Bioscience is headquartered in Redwood City, CA.

  • What is the size of Trellis Bioscience?

    Trellis Bioscience has 20 total employees.

  • What industry is Trellis Bioscience in?

    Trellis Bioscience’s primary industry is Biotechnology.

  • Is Trellis Bioscience a private or public company?

    Trellis Bioscience is a Private company.

  • What is Trellis Bioscience’s current revenue?

    The current revenue for Trellis Bioscience is .

  • How much funding has Trellis Bioscience raised over time?

    Trellis Bioscience has raised $49.1M.

  • Who are Trellis Bioscience’s investors?

    National Institutes of Health, CARB-X, K2X, Nodenza Venture Partners, and National Institute Of Allergy and Infectious Diseases are 5 of 11 investors who have invested in Trellis Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »